| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $18.49B | +7.8% |
| R&D Expense | $95.0M | +3.3% |
| SG&A Expense | $679.0M | +7.6% |
| Interest Expense | $274.0M | +20.7% |
| Pre-tax Income | $806.0M | -38.0% |
| Income Tax | $147.0M | -47.7% |
| Net Income | $658.0M | -31.0% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.50B | +40.0% |
| Accounts Receivable | $1.75B | -32.4% |
| Inventory | $2.73B | -10.2% |
| Current Assets | $6.46B | -13.9% |
| Total Assets | $14.36B | -4.8% |
| Current Liabilities | $4.90B | -24.6% |
| Long-term Debt | $4.94B | -0.5% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.21B | +5.7% |
| Investing Cash Flow | -$775.0M | -63.8% |
| Financing Cash Flow | $24.0M | +103.9% |
| Total Liabilities |
| $10.91B |
| -13.3% |
| Stockholders' Equity | $3.44B | +37.6% |